Repository logo
 
Publication

The neuropharmacology of implicit learning

dc.contributor.authorUdden, Julia
dc.contributor.authorFolia, Vasiliki
dc.contributor.authorPetersson, Karl Magnus
dc.date.accessioned2018-12-07T14:52:50Z
dc.date.available2018-12-07T14:52:50Z
dc.date.issued2010-12
dc.description.abstractTwo decades of pharmacologic research on the human capacity to implicitly acquire knowledge as well as cognitive skills and procedures have yielded surprisingly few conclusive insights. We review the empirical literature of the neuropharmacology of implicit learning. We evaluate the findings in the context of relevant computational models related to neurotransmittors such as dopamine, serotonin, acetylcholine and noradrenalin. These include models for reinforcement learning, sequence production, and categorization. We conclude, based on the reviewed literature, that one can predict improved implicit acquisition by moderately elevated dopamine levels and impaired implicit acquisition by moderately decreased dopamine levels. These effects are most prominent in the dorsal striatum. This is supported by a range of behavioral tasks in the empirical literature. Similar predictions can be made for serotonin, although there is yet a lack of support in the literature for serotonin involvement in classical implicit learning tasks. There is currently a lack of evidence for a role of the noradrenergic and cholinergic systems in implicit and related forms of learning. GABA modulators, including benzodiazepines, seem to affect implicit learning in a complex manner and further research is needed. Finally, we identify allosteric AMPA receptors modulators as a potentially interesting target for future investigation of the neuropharmacology of procedural and implicit learning.
dc.description.sponsorshipMax Planck Institute for Psycholinguistics; Donders Centre for Cognitive Neuroimaging; Stockholm Brain Institute; Fundacao para a Ciencia e Tecnologia (IBB/CBME, LA); Vetenskapsradet; Hedlunds Stiftelse; Stockholm County Council
dc.description.versioninfo:eu-repo/semantics/publishedVersion
dc.identifier.doi10.2174/157015910793358178
dc.identifier.issn1570-159X
dc.identifier.urihttp://hdl.handle.net/10400.1/11230
dc.language.isoeng
dc.peerreviewedyes
dc.publisherBentham Science Publishers
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectEvent related Fmri
dc.subjectBasal Ganglia
dc.subjectPrefrontal cortex
dc.subjectParkinsons disease
dc.subjectCognitive deficits
dc.subjectMemory systems
dc.subjectWorking memory
dc.subjectFrontal cortex
dc.subjectAmpakine
dc.subjectRat
dc.titleThe neuropharmacology of implicit learning
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage381
oaire.citation.issue4
oaire.citation.startPage367
oaire.citation.titleCurrent Neuropharmacology
oaire.citation.volume8
person.familyNamePetersson
person.givenNameKarl Magnus
person.identifier13089
person.identifier.ciencia-id6D14-B1D1-1532
person.identifier.orcid0000-0002-8245-0392
person.identifier.ridE-8188-2012
person.identifier.scopus-author-id7006470225
rcaap.rightsopenAccess
rcaap.typearticle
relation.isAuthorOfPublication0f437ab3-c630-40ad-963f-13196ad4fbd6
relation.isAuthorOfPublication.latestForDiscovery0f437ab3-c630-40ad-963f-13196ad4fbd6

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
The Neuropharmacology of Implicit Learning.pdf
Size:
477.75 KB
Format:
Adobe Portable Document Format